EContra One-Step

Product NDC: 50102-211
Requested package NDC: 50102-211-16
11-digit product format: 501020211
Labeler code: 50102
Product ID: 50102-211_d56023fd-6224-4727-bf3e-e5827dfe5f0a
Type: HUMAN OTC DRUG
Nonproprietary name: Levonorgestrel
Dosage form: TABLET
Route: ORAL
Labeler: Afaxys Pharma, LLC
Application: ANDA206867
Marketing category: ANDA
Marketing start: 2018-02-08
Substance: LEVONORGESTREL
Active strength: 1.5 mg/1
Pharmacologic classes: Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50102-211	50102-211-16	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206867-001	ATHENTIA NEXT	LEVONORGESTREL	1.5MG	TABLET / ORAL			2015-12-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A206867-001	ATHENTIA NEXT	1.5MG	TABLET / ORAL	2015-12-08	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: EContra One-Step
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVONORGESTREL	1.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5W7SIA7YZW	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
483325	Internal RxNorm lookup
1600602	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
94b23c49-dfba-4a70-ada5-e5c212e703c5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
8511fc19-172b-4e1f-90ec-2f09c85b16de	Product name	2	20250116
a0f93f28-4e91-4bb1-8dcb-5456fd4bfc50	Product name	3	20230718
fa479cfe-0bd0-7366-d57a-92f3682e87c5	Product name	3	20210518
20e1a411-dba8-4afa-b9f9-1205d5b0bde9	Product name	3	20210513
5956a0e2-c373-452c-bdcf-c93d354432ef	Product name	1	20200714
ca306105-d51c-4821-9ec1-8eec753d073d	Product name	1	20200619
d2c4820a-bb24-f61d-8cd0-dd0290a6bd4d	Product name	7	20190612
f92411e4-13dd-7baf-106e-9b3fcf758c39	Product name	4	20190502
f713a022-3e1c-4035-bc91-62131bc80b42	Product name	2	20190125
79d5025d-8129-440a-b861-6df2d2661609	Product name	3	20180607
d871c48c-6b0b-4203-b55d-72ead21ea7ad	Product name	5	20180419
12434b90-2738-45d5-9e1b-55001e853273	Product name	2	20171122
741e98f2-ac6c-4d80-9ca8-c663c171ba1d	Product name	1	20161121
cc765024-f257-4c67-b780-c356aadd6980	Product name	3	20150902
5a9b579b-8431-5b3a-2ba4-86556704f873	Product name	1	20140508
5f44c957-835a-ada0-662f-5b1071b7a68b	Product name	1	20140508
d03a75af-b11b-673b-268b-318050d0b3bd	Product name	1	20140508
d0cc7d42-77a7-b452-c6c3-a162fa11225f	Product name	1	20140508
e5ccd419-1745-560a-1e25-c6e3941c710a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50102-211-01	EContra One-Step	1 in 1 BLISTER PACK	TABLET	1	11
50102-211-11	EContra One-Step	1 in 1 CARTON	TABLET	1	11
50102-211-13	EContra One-Step	3 in 1 PACKAGE	TABLET	3	11
50102-211-16	EContra One-Step	6 in 1 PACKAGE	TABLET	6	11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50102-211-01	EA - Each	50102-211	f18df1f3-ebfb-4a94-bd48-4f01ec316406	1	2018-04-19
50102-211-11	EA - Each	50102-211	9aa38692-73d8-4167-889f-2d47d73af0af	1	2018-04-19
50102-211-13	EA - Each	50102-211	5dc0aae8-afd5-4995-9c1d-b350bdce189e	1	2021-06-02
50102-211-16	EA - Each	50102-211	025df1b4-f929-43f6-a2a0-4da0d9d7a23a	1	2018-04-19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50102-211	ECONTRA ONE-STEP (LEVONORGESTREL) TABLET [AFAXYS PHARMA, LLC]	11	Current NDC, Legacy NDC, 4 package rows	20250410_94b23c49-dfba-4a70-ada5-e5c212e703c5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levonorgestrel	LEVONORGESTREL	Rugby Laboratories	076126e4-9d76-45cd-a86b-5b35c56b620a	2026-05-13	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Julie Morning After Pill	LEVONORGESTREL	Julie Products Inc.	40bb96f0-d5f1-1ec3-e063-6294a90a74b1	2025-11-26	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Julie Morning After Pill	LEVONORGESTREL	Julie Products Inc.	40bbad6f-0c54-e4ed-e063-6394a90af3ad	2025-11-14	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
EContra One-Step	LEVONORGESTREL	Afaxys Pharma, LLC	94b23c49-dfba-4a70-ada5-e5c212e703c5	2025-04-08	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867 ndc (package): 50102-211-16 ndc (product): 50102-211 ndc11 (package): 50102021116
Julie	LEVONORGESTREL	Julie Products Inc.	8fb303ec-3b6a-47ac-9ad9-83ab6f0d6ae8	2025-04-07	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
ITHAPPENZ MORNING AFTER	LEVONORGESTREL	Aurohealth LLC	5ee40793-0121-4b8f-b20d-3178bbe262e2	2025-04-07	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Julie	LEVONORGESTREL	Julie Products Inc.	8d20510f-a4e8-4d4b-a96a-f0da91785833	2025-04-07	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Econ Morning After	LEVONORGESTREL	Aurohealth LLC	177daa65-2e7d-4ff4-887e-b927d6ed8825	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Levonorgestrel	LEVONORGESTREL	LEADER/ CARDINAL HEALTH 110, INC.	c7d3a74e-37c4-4c49-861c-64ef363d5a53	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Fem Choice morning after	LEVONORGESTREL	Aurohealth LLC	14051537-9d6c-4f73-a6e9-5eed554bbf65	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
AMAZON BASIC CARE LEVONORGESTREL	LEVONORGESTREL	Amazon.com Services LLC	10ecae6f-386f-e199-e063-6294a90a680b	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Athentia Next	LEVONORGESTREL	Aurohealth LLC	34e5aa53-3943-4e2f-93aa-b5a4d779a703	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
After Banger	LEVONORGESTREL	Aurohealth LLC	791a2461-971c-4191-8905-5a449c600a49	2025-04-04	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867
Morning After	LEVONORGESTREL	Rapha Pharmaceuticals, Inc.	677aa953-3c30-4ce5-e053-2991aa0ab2b2	2018-03-15	Warnings	Exact identifier application applno (ANDA): 206867 application number: ANDA206867

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5W7SIA7YZW	LEVONORGESTREL	797-63-7	LEVONORGESTREL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1600602	EContra EZ Emergency Contraceptive 1.5 MG Oral Tablet	PSN	94b23c49-dfba-4a70-ada5-e5c212e703c5	11
483325	levonorgestrel 1.5 MG Oral Tablet	PSN	94b23c49-dfba-4a70-ada5-e5c212e703c5	11
1600602	levonorgestrel 1.5 MG Oral Tablet [EContra]	SBD	94b23c49-dfba-4a70-ada5-e5c212e703c5	11
483325	levonorgestrel 1.5 MG Oral Tablet	SCD	94b23c49-dfba-4a70-ada5-e5c212e703c5	11
1600602	EContra 1.5 MG Oral Tablet	SY	94b23c49-dfba-4a70-ada5-e5c212e703c5	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50102-211-16	50102021116	6 CARTON in 1 PACKAGE (50102-211-16) > 1 BLISTER PACK in 1 CARTON (50102-211-11) > 1 TABLET in 1 BLISTER PACK (50102-211-01)	6 carton	2018-02-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
EContra One-Step ® (Levonorgestrel) Tablet 1.5 mg	Afaxys Pharma, LLC \| Aurobindo Pharma Limited	2025-04-08	Human OTC Drug Label	11